NL-OMON27543暂停不适用
An international randomized trial in Locally Advanced Breast Cancer comparing 6 courses of neo-adjuvant doxorubicin and cyclophosphamide plus GM-CSF or G-CSF with a split-course administration of 3 neo-adjuvant and 3 adjuvant cycles including either GM-CSF or G-CSF.
VU medisch centrum0 个研究点目标入组 720 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 720
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically proven breast cancer;
- •2. Locally advanced breast cancer: stage IIB with a primary breast tumor > 5 cm ©ª (T3 tumor), IIIA or IIIB according to the AJCC criteria;
排除标准
- •1. Pregnant, or lactating patients. Patients of childbearing potential must use adequate contraception;
- •2. Distant metastases;
研究者
相似试验
进行中（未招募）
不适用
First International Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)EUCTR2005-004137-18-ATCollaborative group for Adrenocortical Carcinoma Therapy (COAT)300
已完成
不适用
First International Randomised trial in Locally Advanced and Metastatic Adrenocortical Cancer Treatment - Etoposide, Doxorubicin, Cisplatin and Mitotane versus Streptozotocin and MitotaneAdrenocortical CarcinomaCancerAdrenocortical carcinomaISRCTN94256573Collaborative group for Adrenocortical Carcinoma Therapy (CO-ACT) (Germany)300
撤回
2 期
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANYSARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19NCT04575064Professor Dr. Bernd Mühlbauer400
已完成
不适用
An international multicentre randomised trial comparing general anaesthetic versus local anaesthetic for carotid surgeryISRCTN00525237The Health Foundation (UK)3,526
尚未招募
3 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19Covid-19B34.2LBCTR2020043495WHO1,000